Consensus estimates for Aeluma's first fiscal quarter of 2027 (calendar Q3 2026) project revenue of $0.52 million and an EPS of -$0.13, with the stock currently trading at $7.12, well below the average analyst price target of $21.42.
Investors are primarily focused on the company's commercialization progress within the AI datacom sector, specifically the transition from government-funded R&D to high-volume commercial production.
Aeluma recently signed a $30 million letter of intent with the U.S. CHIPS Office to scale its photonics platform for AI and advanced computing. This development, alongside new manufacturing partnerships with Tower Semiconductor, is intended to address supply chain constraints in legacy indium phosphide technology.